Skip to main content

Table 1 Study Population.

From: Expression profiling in canine osteosarcoma: identification of biomarkers and pathways associated with outcome

Unique ID

DFI

Age at Dx (yrs)

Sex

Breed

Tumor Site

Tumor

Subtype

Chemotherapy Received

184844

40

4.4

MC

Greyhound

L Prox Humerus

Osteoblastic

Doxorubicin

208911

60

8.0

FS

Doberman

L Prox Humerus

Giant cell

Carboplatin

173175

69

5.0

MC

Rottweiler

L Dist Femur

Osteoblastic

Cisplatin

223986

77

7.0

MC

Greyhound

L Dist Femur

Osteoblastic

Carboplatin

153599

90

9.0

FS

Mix

L Tibia

Giant cell

Cisplatin

222189

91

6.1

FS

Greyhound

L Prox Humerus

Osteoblastic

Doxo & Carbo

204714

94

8.0

FS

Greyhound

L Prox Tibia

Giant Cell

Doxorubicin

208756

95

10.2

FS

Labrador Ret.

L Dist Humerus

Osteoblastic

Cisplatin

146719

97

8.8

MC

Mix

R Dist Femur

Fibroblastic

Doxorubicin

212759

97

10.8

MC

Golden Ret.

L Prox Humerus

Osteoblastic

Doxorubicin

177466

307

7.6

FS

Mix

L Dist Radius

Osteoblastic

Cisplatin

188084

329

10.4

MC

Rottweiler

R Dist Radius

PD

Doxorubicin

190030

356

13.4

MC

Mix

L Dist Humerus

Osteoblastic

Doxorubicin

180223

384

11.5

FS

Mix

R Prox Femur

Osteoblastic

Cisplatin

208513

467

7.1

MC

Greyhound

L Prox Humerus

Osteoblastic

Doxorubicin

180119

619

10.4

FS

Mix

R Dist Femur

Osteoblastic

Cisplatin

193231

694

12.4

MC

Mix

L Dist Radius

Osteoblastic

Doxorubicin

174513

734

10.1

FS

Malamute

L Dist Radius

Osteoblastic

Doxo & Carbo

155214

787

8.7

MC

Labrador Ret.

R Tibia

Osteoblastic

Doxorubicin

168327

885

8.0

FS

Golden Ret.

L Dist Radius

Osteoblastic

Carboplatin

  1. DFI = disease-free interval, Dx = diagnosis, MC = castrated male, FS = spayed female, L = left, Dist = distal, Prox = proximal, R = right, PD = poorly-differentiated, "Doxo & Carbo" = Doxorubicin and Carboplatin combination therapy,